Clinical Trial Update: Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tamoxifen with or without octreotide in postmenopausal women with Stage I-III breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED